FDA, Health Services Administration, Medicaid and Telemedicine

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Health Services Administration

Medicaid

Telemedicine

Expanded Medicare Telehealth Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs

Healthcare Law Today

NOVEMBER 9, 2022

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” In 2020, CMS established a new Part B benefit category for opioid use disorder (OUD) treatment provided by OTPs. Want to Learn More?

Medicare

Medicare Medicare COVID-19 Telemedicine

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps

Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone. Code § 1701 et seq.

Governance

Governance Public Health Telemedicine Medicaid

Health Care Compliance Brief

Expanded Medicare Telehealth Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps

Stay Connected